MolNFT v1 · #174319 · protein
Crystal structure of human FAM134B lir fused to human gabarap
7BRQ · Reticulophagy regulator 1,GAMMA-aminobutyric acid receptor…: “Crystal structure of human FAM134B lir fused to human gabarap”. X-ray diffraction. MolNFT v1 #174319 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 7BRQ
- Type
- protein
- Length
- 132 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Reticulophagy regulator 1,GAMMA-aminobutyric acid receptor- associated protein
- UniProt
- Q9H6L5, O95166
Structure
x-ray diffraction · 1 distinct chain · 31% helix, 20% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Reticulophagy regulator 1,GAMMA-aminobutyric acid receptor- associated protein | protein | 132 | 31% helix, 20% strand | Q9H6L5, O95166 |
Ligands and binding sites
- GOL · Glycerol · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 7BRQ · Crystal structure of human FAM134B LIR fused to human GABARAP · the same entry in another collection · chain A against A, TM-score 1.00
- O95166 · AlphaFold monomer V2.0 prediction for gamma-aminobutyric acid receptor-associated protein… · a predicted model of the same protein · chain A against A, TM-score 0.85
- Q9H6L5 · AlphaFold monomer V2.0 prediction for reticulophagy regulator 1 (Q9H6L5) · a predicted model of the same protein · chain A against A, TM-score 0.29
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9H6L5
- Every structure of UniProt O95166
- Elsewhere: RCSB PDB 7BRQ · PDBe 7BRQ · UniProt Q9H6L5 · UniProt O95166
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.